Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
about
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activityThe homeobox only protein homeobox (HOPX) and colorectal cancerPortal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood-deprived liver tissue.Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implicationsHigh expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for TreatmentMet degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail.Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional eventsOverexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.Molecular parameters of head and neck cancer metastasis.Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammationEpstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Role of cytokines in head and neck squamous cell carcinoma.Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 statusHepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells.Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 geneGene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease.A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem CellsThe Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.Current and potential inflammation targeted therapies in head and neck cancer.The role of antiangiogenic agents in the treatment of head and neck cancer.Involvement of HTLV-I Tax and CREB in aneuploidy: a bioinformatics approachEarly growth response protein-1 (Egr-1) is preferentially expressed in T helper type 2 (Th2) cells and is involved in acute transcription of the Th2 cytokine interleukin-4.Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia.Prostanoids induce egr1 gene expression in cementoblastic OCCM cells.PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.
P2860
Q24546366-63F7ABAA-3730-4ECD-A88E-B0A5331366DDQ27004699-82DBDE7F-54E9-4105-8A99-EA21CCBC1455Q33277527-44F55AB6-F102-43CA-9FCC-DB6572B2F35EQ33320268-C2A7A80C-BD21-497E-A547-006EC847640DQ33348043-54EC20A4-1206-4E9D-B7D2-AF9E9616DFE4Q33607965-E7CC808E-E9C4-410E-A0FB-500DB7E64540Q33654173-7662F65B-EBCB-4231-A6C6-BA0D08BC7442Q33768073-CA11D316-0F1E-4398-BE7A-93CABC093E86Q34349271-084D6078-830A-49A3-8BBA-F7A7F37B1FAFQ34388854-1F9096F7-649D-4742-BFE0-858C86A351B3Q34902060-56A82D4A-89C7-4F25-AF68-3F25E9867D34Q34972866-441D2567-32E2-49E6-9693-3398860CF3B5Q34998769-48D2D66C-8EC7-45DC-B0F3-2950DA0B15BBQ35197405-B86AF1EC-E40A-4BC0-A929-F1CCE8B6FF2EQ35570393-A2A1BB7C-5FC7-488D-8977-73EADFA6C0F4Q35582737-3F5B8DC1-1464-498F-B64F-99F356F48DE7Q35585465-33DF825F-E114-410F-B94C-FB97D1CB725BQ35906476-B4162BF3-DCBE-4901-8DF2-316675562CF9Q36021572-CFE285AC-0AB0-4A16-8B46-DE55B68E49DDQ36238438-73F6A073-1A08-46C9-A55C-D5421A84CBB6Q36498181-97D235A8-58BE-4D6E-B17B-2C37AEBE14F6Q36613975-6E96AD49-BC5B-4537-8DE2-DC28C6D42091Q36678582-7E8766A9-690C-4DFC-A01A-9BF1B4441BC0Q36719452-8BB00A13-B751-46A6-ACE1-03E320DCB71EQ36737414-DE501444-19AC-403A-8C23-EB1930D3767EQ36749173-60B8F069-3D0D-4216-B72D-397C9CDE6D64Q36809751-0B3D1406-F9C6-42D7-9C3D-0AA4C4F202B4Q36898247-E2F3B34B-A9F0-44EB-A3A6-D2E98BA39E7EQ37189951-447849CD-8CA0-41B5-89EC-017D95F54B4DQ37316179-699D9865-E4DE-4312-BB5A-18DAD40D3B71Q38025003-B19CA0D6-38DD-494B-A193-63F7FF4CB7B7Q38311746-DEF98230-4F39-4165-9C15-246CBE3C0A90Q38348879-4D48D253-D634-4A28-97E0-D037EAB418E0Q39340968-1CA0C852-5EBC-4083-9F4B-70E3A5AF511EQ39650224-1C6DC31D-D681-4B0F-8B3F-84147F66C517Q40087300-2263862B-71D0-4D5E-A942-72413C7F2B4FQ40490330-698A442B-1C98-4CD2-83DE-853B3F166BC7Q43214053-E4D9CB26-1E57-48EF-A04C-765CF445207FQ54567802-1B387954-4723-40BE-BEE5-DF814F03A700
P2860
Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hepatocyte growth factor/scatt ...... neck squamous cell carcinoma.
@en
type
label
Hepatocyte growth factor/scatt ...... neck squamous cell carcinoma.
@en
prefLabel
Hepatocyte growth factor/scatt ...... neck squamous cell carcinoma.
@en
P2093
P1433
P1476
Hepatocyte growth factor/scatt ...... neck squamous cell carcinoma.
@en
P2093
Brian Worden
Carter Van Waes
Joshua G Cohen
Lorena Bagain
Ning T Yeh
Tin Lap Lee
Xin Ping Yang
Zhong Chen
P304
P356
10.1158/0008-5472.CAN-04-0989
P407
P577
2005-08-01T00:00:00Z